Thus, we performed a study aiming to elucidate the association between TMB, CD8+TILs, and clinical factors in patients with cervical cancer treated with definitive radiotherapy by collecting the cases available for somatic mutation data and immunohistochemical staining data from identical tumor tissues. This evidence concerns the gene CD8A and cervical cancer.